Murphy Matthew B. bought NAUT
September 4, 2025 · Form 4 insider transaction
Murphy Matthew B. bought 20,000 shares of Nautilus Biotechnology, Inc. at $0.64 per share, a transaction worth $12.9K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
20,000
Price
$0.64
Total value
$12.9K
InsiderMurphy Matthew B.
Role—
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateSeptember 4, 2025
Filing dateSeptember 5, 2025
Shares owned after74,140
OwnershipIndirect
10b5-1 planNo
AmendedNo
Footnotes
Shares held by the Murphy Family Trust. The reporting person is the Trustee of the Murphy Family Trust.